{"product_id":"proteogenix-ivonescimab-biosimilar-anti-vegf-pd1-mab-research-grade","title":"Ivonescimab Biosimilar – Anti-VEGF \u0026 PD1 mAb – Research Grade","description":"\u003ch2\u003eWhat is Ivonescimab?\u003c\/h2\u003e \u003cp\u003eIvonescimab (AK112) is an antibody developed to target both PD-1 and VEGF pathways, two key mechanisms involved in immune regulation and angiogenesis. It is widely studied in immuno-oncology research for its ability to modulate tumor immune responses while impacting vascular development.\u003c\/p\u003e \u003ch3\u003eMechanism of Action\u003c\/h3\u003e \u003cp\u003eThis ivonescimab antibody is used in research to explore combined inhibition of PD-1-mediated immune checkpoint signaling and VEGF-driven angiogenesis. Such dual pathway targeting is of particular interest in studies of tumor progression and therapeutic response.\u003c\/p\u003e \u003ch3\u003eApplications\u003c\/h3\u003e \u003cul\u003e \u003cli\u003eImmuno-oncology research\u003c\/li\u003e \u003cli\u003ePD-1 immune checkpoint studies\u003c\/li\u003e \u003cli\u003eAngiogenesis and VEGF pathway analysis\u003c\/li\u003e \u003cli\u003eCombination therapy research\u003c\/li\u003e \u003cli\u003ePreclinical evaluation of antibody-based approaches\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eKey Features\u003c\/h2\u003e \u003cul\u003e \u003cli\u003eTargets PD-1 and VEGF-related pathways\u003c\/li\u003e \u003cli\u003eSuitable for advanced research applications\u003c\/li\u003e \u003cli\u003eConsistent performance and reproducibility\u003c\/li\u003e \u003cli\u003eResearch-grade biosimilar format\u003c\/li\u003e \u003c\/ul\u003e \u003ch2\u003eAbout PD-1 and VEGF targeting\u003c\/h2\u003e \u003cp\u003ePD-1 is a key immune checkpoint receptor involved in regulating T-cell activity, while VEGF plays a central role in angiogenesis. Targeting both pathways is widely investigated in oncology research to better understand tumor immune evasion and vascular development.\u003c\/p\u003e \u003ch2\u003eIvonescimab Antibody Price and Cost\u003c\/h2\u003e \u003cp\u003eThe price of ivonescimab antibody depends on the required format, quantity, and research specifications. ProteoGenix provides high-quality biosimilars at competitive cost, ensuring accessibility for research applications.\u003c\/p\u003e \u003cp\u003e\u003cstrong\u003eFor detailed pricing or bulk orders, you can request a quote directly from our team.\u003c\/strong\u003e\u003c\/p\u003e \u003ch2\u003eNeed a tailored antibody solution?\u003c\/h2\u003e \u003cp\u003eIf your research requires specific antibody formats or optimized targeting strategies, custom antibody development solutions can support advanced experimental needs.\u003c\/p\u003e\u003cp\u003eProteoGenix catalogue number PX-TA1763. For research use only.\u003c\/p\u003e\u003cp\u003eTarget: Ivonescimab Biosimilar – Anti-VEGF \u0026amp; PD1 mAb – Research Grade; Clonality: Monoclonal Antibody; Expression system: XtenCHO; Buffer: PBS buffer PH7.5; Applications: ELISA, WB, Flow Cyt.\u003c\/p\u003e\u003cp\u003eAvailable configurations: 50ug, 100ug, 1mg.\u003c\/p\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.proteogenix.science\/wp-content\/uploads\/documents\/Datasheets\/PX-TA1763.pdf\"\u003eDownload the manufacturer datasheet\u003c\/a\u003e\u003c\/p\u003e","brand":"ProteoGenix","offers":[{"title":"50ug","offer_id":57357664452948,"sku":"ABM134289-1","price":144.0,"currency_code":"USD","in_stock":true},{"title":"100ug","offer_id":57357664485716,"sku":"ABM134289-2","price":211.0,"currency_code":"USD","in_stock":true},{"title":"1mg","offer_id":57357664518484,"sku":"ABM134289-3","price":451.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/1782\/2036\/files\/bioactivity-validation-2-ivonescimab-biosimilar-anti-vegf-pd1-mab-research-grade_5570f538-8944-4cf8-bfaa-adaba5f6712d.jpg?v=1790890889","url":"https:\/\/www.abmium.com\/products\/proteogenix-ivonescimab-biosimilar-anti-vegf-pd1-mab-research-grade","provider":"ABMIUM","version":"1.0","type":"link"}